Global PV Oversight for China Development Programs

As development programs expand across different sponsorship models, countries, vendors, and regulatory environments, pharmacovigilance oversight can become fragmented. For sponsors running IIS activities in China while preparing for future IND development, early PV alignment is critical to protect safety data consistency, strengthen operational control, and support better regulatory decision-making.

PrimeVigilance supports pharmaceutical and biotech sponsors with centralized global PV oversight in coordination with local Chinese sponsors, partners, and stakeholders. Our teams help maintain local compliance while preserving global safety consistency, oversight, and governance across the broader development program.

From global safety case intake and SAE reconciliation to aggregate reporting, signal detection, literature monitoring, medical review, SOP alignment, and vendor oversight, PrimeVigilance helps sponsors build scalable PV operating models that support both current China IIS activity and future IND-enabling studies.

By integrating China-specific activities into a unified global PV framework, PrimeVigilance helps reduce duplication, improve traceability, support inspection readiness, and define clear roles between global PV teams, local sponsors, CROs, regional partners, and investigators.

Download our brochure to learn more.

Strengthen safety governance from IIS to IND development, contact us to learn more.